• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.68% Nasdaq Up0.58%

    Epizyme, Inc. (EPZM)

    -NasdaqGS
    22.63 Down 1.37(5.71%) 11:55AM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
    Total Revenue 41,411   68,482   45,222  
    Cost of Revenue -   -   -  
    Gross Profit 41,411   68,482   45,222  
    Operating Expenses
    Research Development75,595  57,567  38,482  
    Selling General and Administrative20,866  14,042  7,508  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (55,050) (3,127) (768)
    Income from Continuing Operations
    Total Other Income/Expenses Net154  (7)67  
    Earnings Before Interest And Taxes(54,896)(3,134)(701)
    Interest Expense -   -   -  
    Income Before Tax(54,896)(3,134)(701)
    Income Tax Expense109  349  1  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(55,005)(3,483)(702)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (55,005) (3,483) (702)
    Preferred Stock And Other Adjustments -  (264)(486)
    Net Income Applicable To Common Shares (55,005) (3,747) (1,188)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.